🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

62,31 USD

Máx. histórico

108,06

1030 días

Split 1:6 del 25/06/2013

Caída desde máximo

-42,34%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+0,45%

Cierre anterior

62,03

Rango de hoy

62,05 – 64,37

Volumen hoy

1.699.286

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 20 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/09/2024 54,31 56,26 54,17 55,83 +3,22% 3,85% 1.180.100
06/09/2024 56,19 56,36 53,21 54,09 -3,29% 5,61% 1.396.400
05/09/2024 55,50 56,87 54,68 55,93 +1,89% 3,95% 1.135.100
04/09/2024 54,29 55,05 53,16 54,89 +0,60% 3,48% 2.056.800
03/09/2024 56,72 57,80 54,22 54,56 -4,41% 6,31% 1.633.100
30/08/2024 57,94 57,98 56,28 57,08 -0,54% 2,93% 1.080.800
29/08/2024 55,99 58,68 55,21 57,39 +3,35% 6,20% 1.329.300
28/08/2024 55,43 55,92 55,02 55,53 -0,57% 1,62% 567.500
27/08/2024 56,73 57,22 55,32 55,85 -2,14% 3,35% 965.700
26/08/2024 57,56 58,05 56,85 57,07 -0,44% 2,08% 625.400
23/08/2024 56,57 57,94 56,21 57,32 +1,90% 3,06% 1.206.700
22/08/2024 56,83 56,91 55,43 56,25 -0,58% 2,60% 838.000
21/08/2024 57,00 58,21 56,22 56,58 -0,47% 3,49% 759.200
20/08/2024 56,37 57,23 55,58 56,85 +0,69% 2,93% 1.514.800
19/08/2024 56,56 57,38 55,63 56,46 -0,07% 3,09% 1.497.400
16/08/2024 56,73 57,45 55,68 56,50 -0,98% 3,12% 1.246.000
15/08/2024 57,46 57,73 56,30 57,06 +2,11% 2,49% 1.192.900
14/08/2024 55,92 56,07 54,87 55,88 -0,34% 2,15% 805.600
13/08/2024 54,74 56,34 53,94 56,07 -0,20% 4,38% 2.113.400
12/08/2024 56,18 57,14 54,35 56,18 +0,70% 4,97% 946.400
09/08/2024 52,00 56,43 51,92 55,79 +3,31% 8,67% 1.819.200
08/08/2024 51,39 54,47 51,17 54,00 +5,43% 6,42% 1.721.600
07/08/2024 53,93 53,93 51,05 51,22 -4,33% 5,34% 1.474.600
06/08/2024 53,55 54,83 53,21 53,54 +0,21% 3,03% 949.200
05/08/2024 53,10 56,13 53,00 53,43 -6,49% 5,89% 2.036.500
02/08/2024 55,97 57,57 55,49 57,14 -1,33% 3,72% 1.322.600
01/08/2024 58,95 59,81 57,85 57,91 -1,86% 3,32% 1.047.600
31/07/2024 60,30 61,27 58,67 59,01 -1,91% 4,31% 1.321.500
30/07/2024 59,44 60,54 58,67 60,16 +1,81% 3,15% 923.500
29/07/2024 59,61 60,20 57,53 59,09 -1,01% 4,48% 1.209.800